About this Journal Submit a Manuscript Table of Contents
International Journal of Endocrinology
Volume 2012 (2012), Article ID 296485, 9 pages
http://dx.doi.org/10.1155/2012/296485
Review Article

Genetically Engineered Islets and Alternative Sources of Insulin-Producing Cells for Treating Autoimmune Diabetes: Quo Vadis?

1Department and Graduate Institute of Microbiology and Immunology, National Defense Medical Center, Neihu, Taipei 114, Taiwan
2Department of General Surgery, Tri-Service General Hospital, Taipei 114, Taiwan

Received 22 October 2011; Accepted 29 March 2012

Academic Editor: Subbiah Pugazhenthi

Copyright © 2012 Feng-Cheng Chou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Feng-Cheng Chou, Shing-Hwa Huang, and Huey-Kang Sytwu, “Genetically Engineered Islets and Alternative Sources of Insulin-Producing Cells for Treating Autoimmune Diabetes: Quo Vadis?,” International Journal of Endocrinology, vol. 2012, Article ID 296485, 9 pages, 2012. doi:10.1155/2012/296485